Table 1.
Characteristic of patients with Cushing disease and microincidentaloma in the context of COVID-19 pandemic
| Cushing disease N = 61 | Controls N = 61 | |
|---|---|---|
| Age (years)a | 52.6 ± 12.4 | 52.7 ± 11.7 |
| Females | 51 (83.3%) | 51 (83.3%) |
| Smoking | 8 (13.1%) | 11 (18%) |
| Influenza vaccination | 20 (32.7%) | 16 (26.3%) |
| Profession at risk | 10 (16.4%) | 7 (11.5%) |
| Daily travel for work | 8 (13.1%) | 7 (11.5%) |
| Use of public transportation | 2 (3.2%) | 2 (3.2) |
| N° of cohabitantsb | 1 (0–5) | 2 (0–5) |
| N° cases SSc + : Jan to 15 Apr | 23 (37.7%) | 29 (47.5%) |
| N° cases SS + : Mar to 15 Apr | 9 (14.7%) | 15 (24.6%) |
| N°SS: Mar to 15 Apr | 3 (1–7) | 2 (1–6) |
| Cough and fever | 4 (6.5%) | 1 (1.6%) |
| At least 3 SS for 1 week min | 4 (6.5%) | 2 (3.2%) |
| Nasopharyngeal swab | 2 (3.2%) | 3 (4.9%) |
| COVID-19 + | 2 (3.2%) | 0 |
aMean ± Standard deviation
bMedian (range)
cSigns and symptoms